NO20065339L - Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse - Google Patents

Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse

Info

Publication number
NO20065339L
NO20065339L NO20065339A NO20065339A NO20065339L NO 20065339 L NO20065339 L NO 20065339L NO 20065339 A NO20065339 A NO 20065339A NO 20065339 A NO20065339 A NO 20065339A NO 20065339 L NO20065339 L NO 20065339L
Authority
NO
Norway
Prior art keywords
liposomes
topical
active ingredient
cutaneous
relates
Prior art date
Application number
NO20065339A
Other languages
English (en)
Norwegian (no)
Inventor
Eberhard Pirich
Werner Frantsits
Angelika Bodenteich
Josef Bockmann
Andreas Wagner
Karola Vorauer-Uhl
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of NO20065339L publication Critical patent/NO20065339L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20065339A 2004-04-22 2006-11-21 Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse NO20065339L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0069604A AT500143A1 (de) 2004-04-22 2004-04-22 Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung
PCT/AT2005/000138 WO2005102268A2 (de) 2004-04-22 2005-04-21 Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
NO20065339L true NO20065339L (no) 2007-01-09

Family

ID=35197479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065339A NO20065339L (no) 2004-04-22 2006-11-21 Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse

Country Status (10)

Country Link
US (1) US20080031935A1 (ru)
EP (1) EP1737426A2 (ru)
JP (1) JP2007533666A (ru)
CN (1) CN1946377A (ru)
AT (1) AT500143A1 (ru)
AU (1) AU2005235430A1 (ru)
CA (1) CA2563861A1 (ru)
NO (1) NO20065339L (ru)
RU (1) RU2006141254A (ru)
WO (1) WO2005102268A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1881756B1 (en) * 2005-02-11 2016-08-10 Stephen Wills Treating microvasculature diseases with acetyl cholinesterase inhibitors
EP1901733B1 (en) 2005-05-23 2016-04-06 President and Fellows of Harvard College Huperzine for use in the treatment of neuropathic pain
DE102006056783A1 (de) * 2006-12-01 2008-06-05 Lts Lohmann Therapie-Systeme Ag Zubereitung zur transdermalen Verabreichung von Galanthamin
TWI428135B (zh) * 2007-03-26 2014-03-01 Hirofumi Takeuchi And a carrier composition for quick-acting nucleic acid delivery
CN103370055B (zh) * 2011-03-25 2015-06-24 泰尔茂株式会社 缓释性脂质体组合物及其制造方法
JP5848511B2 (ja) * 2011-03-29 2016-01-27 株式会社コーセー リポソーム組成物、並びにそれを用いた化粧料、皮膚外用剤及びその製造方法
CN102178680B (zh) * 2011-04-24 2012-09-05 浙江现代中药与天然药物研究院有限公司 一种长效高含量的石杉碱甲贴片及其制备方法
US9685730B2 (en) 2014-09-12 2017-06-20 Steelcase Inc. Floor power distribution system
GB2561157A (en) * 2017-03-27 2018-10-10 Univ Oxford Innovation Ltd Compartmentalised gel matrix and method of production
KR102046355B1 (ko) * 2018-02-08 2019-11-19 국방과학연구소 피하주사용 피소스티그민의 서방출성 리포좀 제제 및 이의 제조 방법
CN112512508A (zh) * 2018-07-24 2021-03-16 台湾微脂体股份有限公司 含有治疗失智症的治疗剂的缓释药物组合物及其用途
CN112512509A (zh) * 2018-08-02 2021-03-16 台湾微脂体股份有限公司 含有治疗抑郁症或焦虑症的治疗剂的缓释组合物及其用途
EP3833333A4 (en) * 2018-08-08 2022-05-04 Taiwan Liposome Company, Ltd. DELAYED RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIPSYCHOTIC ACTIVE INGREDIENT AND THEIR USES

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942200A (en) * 1959-03-02 1963-11-20 Chimiko Pharmazevtitschen Zd A method of obtaining galanthamine hydrobromide
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
DE3843239C1 (ru) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
WO1990014105A1 (en) * 1989-05-15 1990-11-29 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
IT1254464B (it) * 1992-02-17 1995-09-25 Enzo Anaclio Uso di sostanze parasimpaticomimetiche dirette per la terapia del dolore.
CA2097163C (en) * 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5837282A (en) * 1996-10-30 1998-11-17 University Of British Columbia Ionophore-mediated liposome loading
IT1304904B1 (it) * 1998-09-11 2001-04-05 Eisai Co Ltd Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
WO2001035927A2 (en) * 2000-11-16 2001-05-25 El Khoury George F Topical application of muscarinic analgesic drugs such as neostigmine
PL202463B1 (pl) * 2000-03-31 2009-06-30 Sanochemia Pharmazeutika Ag Pochodne galantaminy, sposób ich wytwarzania, środek leczniczy zawierajacy te pochodne, zastosowanie pochodnej galantaminy do wytwarzania środków leczniczych, sposób wytwarzania środków leczniczych oraz sposób oddzielania (+)- i (-)-izomerów
EP1285656A4 (en) * 2000-04-13 2006-07-12 Eisai Co Ltd ACETYLCHOLINESTERASE HEMMER CONTAINING 1-BENZYLPYRIDINIUM SALT
EP1300395B1 (en) * 2000-06-21 2009-09-02 Eisai R&D Management Co., Ltd. 4-substituted piperidine compound
EP1203614A1 (de) * 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
DK1362844T3 (da) * 2001-01-26 2008-04-14 Btg Int Ltd Benzylaminanalog
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
US20030235609A1 (en) * 2002-01-25 2003-12-25 Lautt Wilfred Wayne Use of cholinesterase antagonists to treat insulin resistance
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid

Also Published As

Publication number Publication date
EP1737426A2 (de) 2007-01-03
AT500143A1 (de) 2005-11-15
US20080031935A1 (en) 2008-02-07
RU2006141254A (ru) 2008-05-27
AU2005235430A1 (en) 2005-11-03
CA2563861A1 (en) 2005-11-03
JP2007533666A (ja) 2007-11-22
WO2005102268A3 (de) 2006-04-06
WO2005102268A2 (de) 2005-11-03
CN1946377A (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
NO20065339L (no) Cholinesteraseinhibitorer i liposomer og deres fremstilling og anvendelse
WO2009011412A3 (en) Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
NO20062703L (no) Maleatsalter av et kinazolinederivater anvenbare som antiangiogenisk middel
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
WO2006040688A3 (en) Inhibitors of acetylcholinesterase for treating skin diseases
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
NO20092018L (no) Fremgangsmater for a behandle depresjon
PT1414467E (pt) Tratamento topico da mastalgia
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
BRPI0414777A (pt) compostos, composições farmacêuticas, uso de um ou mais compostos, e, método de tratar um paciente que sofre de um distúrbio
WO2002043731A3 (en) Treatments for neurogenetic disorders, impulse control disorders, and wound healing
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
BRPI0409881A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
ATE395061T1 (de) Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie
BRPI0409878A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
IL190850A (en) Use of Artemisinin and Derivatives to Prepare a Pharmacist and Insulin Composition Containing Local Compositions Containing Them
AR006578A1 (es) Composiciones fungicidas que comprenden ciprodinil con miclobutanil o iprodiona y que tienen accion sinergica contra las enfermedades de plantas y unmetodo de proteccion contra las enfermedades
NO20055254L (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
WO2008099906A1 (ja) 歯周病、及び外科手術による歯槽骨欠損の治療剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application